CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale Chief Commercial Ofc Imm Med sold 29,390 shares at an average $3.44 ($100,994)
- 4 Open-market sale President sold 39,070 shares at an average $3.47 ($135,764)
- 4 Grant or award Chief Scientific Officer acquired 354,610 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 15,456 shares at $3.44 ($53,169)
- 4 Open-market sale CEO and Chairman sold 48,673 shares at an average $3.43 ($167,007)
- 4 Open-market sale Chief Commercial Officer, MRD sold 12,991 shares at an average $3.44 ($44,629)
- 3 Insider Initial Statement of Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 100,000 shares (option exercise)
- 4 Open-market sale Principal Accounting Officer sold 259 shares at $4.13 ($1,070)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer, MRD sold 16,202 shares at an average $6.62 ($107,318)
Page 15 of 42 · 836 filings